Current Report Filing (8-k)
January 17 2019 - 7:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 17, 2019
HCA HEALTHCARE, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
001-11239
(Commission File Number)
|
|
27-3865930
(IRS Employer
Identification No.)
|
|
|
One Park Plaza, Nashville, Tennessee
(Address of principal executive offices)
|
|
37203
(Zip Code)
|
(615)
344-9551
(Registrants telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
On January 17, 2019, HCA Healthcare, Inc. (the Company) issued a press release (the Press Release) announcing the
commencement of its proposed public offering of $1,000,000,000 aggregate principal amount of senior unsecured notes (the Offering). The text of the Press Release is set forth as
Exhibit 99.1
and is incorporated herein by
reference. In connection with the Offering, the Company is disclosing certain information, some of which was included in the Companys Annual Report on
Form 10-K
for the fiscal year ended
December 31, 2017 (the Disclosure). The text of the Disclosure is set forth as
Exhibit 99.2
and is incorporated herein by reference.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date: January 17, 2019
|
|
|
|
HCA HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
/s/ John M. Franck II
|
|
|
|
|
|
|
John M. Franck II
|
|
|
|
|
|
|
Vice President Legal and Corporate Secretary
|
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Apr 2024 to May 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From May 2023 to May 2024